Concepedia

Steve K. Yoshinaga

SK

Statistics

Publications

4

Citations

946

H-Index

4

Active since

2001

Affiliations

Amgen (United States)(Current)

Mount Sinai Hospital

University of Toronto

Lunenfeld-Tanenbaum Research Institute

University Hospital of Zurich

Steve K. Yoshinaga is an author at Amgen (United States) specializing in immunology, life sciences, and adaptive immunity.

Publications per year

2001–2009

4

Publications

4

ICOS is essential for effective T-helper-cell responses

Arda Shahinian, Friedhelm Bladt, Steve K. Yoshinaga et al. · Nature · 2001 · 667 citations

, , +9

Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell–dependent B cell responses

Tak W. Mak, Arda Shahinian, Steve K. Yoshinaga et al. · Nature Immunology · 2003 · 203 citations

, , +16

A Role for Inducible Costimulator Protein in the CD28- Independent Mechanism of Resistance to <i>Toxoplasma gondii</i>

Eric N. Villegas, Linda A. Lieberman, Nicola J. Mason et al. · The Journal of Immunology · 2002 · 59 citations

, , +17

CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo

Rebecca A. Shilling, Bryan S. Clay, Amanda G. Tesciuba et al. · Cellular Immunology · 2009 · 17 citations · Full text

, , +14

1–4 of 4